TERT and hepatocellular carcinoma: In particular, 11 out of 41 (26.8%) TERT-mutated HCC experienced recurrence, versus 2 out of 26 (7.7%) not mutated cases (p = 0.049; OR = 4.4; 95%CI 0.9–21.8).